Metronomic chemotherapy regimens in oncology

• Main Authors: M. Yu. Fedyanin, I. A. Pokataev, S. A. Tyulyandin
• Format: Article
• Language: Russian
• Published: “ABV-press” Publishing house”, LLC 2016-04-01
• Series: Тазовая хирургия и онкология
• Subjects: colon cancer; metronomic chemotherapy regimens
• Online Access: https://ok.abvpress.ru/jour/article/view/163

Metronomic chemotherapy implies the regular use of cytotoxic agents in doses much smaller than the maximum tolerable doses for a long time. Preclinical experiments show that this treatment option has a many-sided (antiangiogenic, immunostimulating, and direct cytotoxic) effect on tumor. Moreover, this approach has gained the widest acceptance in treating patients with metastatic breast cancer in clinical practice. By taking into account the high activity of angiogenesis in colon cancer progression, it is interesting to study the impact of metronomic chemotherapy regimens for this nosological entity as well. This literature review considers not only the history of metronomic chemotherapy, the mechanisms of action, and a range of drugs having an antitumor effect in the metronomic regimens, but also analyzes clinical trials of metronomic chemotherapy regimens in patients with metastatic colon cancer.